Stockscreener 앱 받기
2.56
1.82%
0.0458
전일 마감가:
$2.5142
열려 있는:
$2.5
하루 거래량:
3,341
Relative Volume:
0.19
시가총액:
$6.05M
수익:
$9.47M
순이익/손실:
$-2.30M
주가수익비율:
-2.0025
EPS:
-1.2784
순현금흐름:
$-2.87M
1주 성능:
+14.80%
1개월 성능:
+7.11%
6개월 성능:
-52.33%
1년 성능:
-17.15%
1일 변동 폭
$2.50
$2.62
1주일 범위
$2.23
$2.68
52주 변동 폭
$1.92
$15.60
Bionexus Gene Lab Corp Stock (BGLC) Company Profile
명칭
Bionexus Gene Lab Corp
전화
1-307-241-6898
주소
10-2 TOWER B, VERTICAL BUSINESS SUITE,, KUALA LUMPUR
Compare BGLC vs MOBBW, PSNYW, GOODO, SHMD, DWLD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BGLC
BioNexus Gene Lab Corp Common stock
|
0.343 | 201.51M | 0 | 0 | 0 | 0.00 |
|
MOBBW
Mobilicom Limited Warrants
|
2.52 | 3.71B | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
4.58 | 414.42M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
GOODO
Gladstone Commercial Corporation
|
19.91 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
6.52 | 377.54M | 52.15M | -21.46M | 0 | -0.4675 |
|
DWLD
Davis Select Worldwide ETF
|
43.90 | 0 | 0 | 0 | 0 | 0.00 |
Bionexus Gene Lab Corp 주식(BGLC)의 최신 뉴스
Tech Rally: Will BioNexus Gene Lab Corp outperform its industry peersPortfolio Profit Report & Free Reliable Trade Execution Plans - baoquankhu1.vn
12 Industrials Stocks Moving In Wednesday's Pre-Market Session - Benzinga
BioNexus Gene Lab (NASDAQ: BGLC) taps new CCO to drive Fidelion VitaGuard MRD commercialization - Stock Titan
BioNexus Gene Lab appoints commercial officer at Fidelion By Investing.com - Investing.com Nigeria
BioNexus Gene Lab appoints commercial officer at Fidelion - Investing.com India
BioNexus Gene Lab Corp. Announces Appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics to Lead Global Commercialization of the VitaGuard MRD Platform - Bitget
BioNexus Gene Lab Corp. Announces Appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics to Lead Global Commercialization of the VitaGuard™ MRD Platform - The Manila Times
BioNexus Gene Lab Corp. Appoints Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics - Quiver Quantitative
Cancer relapse blood tests: Fidelion hires 15-year oncology diagnostics veteran - Stock Titan
12 Industrials Stocks Moving In Monday's Intraday Session - Sahm
Sell Signal: Is BioNexus Gene Lab Corp a strong candidate for buy and holdQuarterly Portfolio Review & Risk Managed Trade Strategies - baoquankhu1.vn
Breakouts Watch: Will BioNexus Gene Lab Corp stock recover after earningsJuly 2025 Levels & Growth Focused Stock Reports - baoquankhu1.vn
BioNexus Gene Lab Corp. Completes Chemrex Governance Restructuring; Appoints Matthew Barsing as Chairman - Bitget
Chemrex board cut to two as BioNexus weighs new growth options - Stock Titan
BGLCBionexus Gene La Latest Stock News & Market Updates - Stock Titan
Financial Comparison: Beauty Health (NASDAQ:SKIN) vs. BioNexus Gene Lab (NASDAQ:BGLC) - Defense World
BioNexus Gene Lab (NASDAQ:BGLC) Stock Price Up 1.7% – Still a Buy? - Defense World
Sentiment Review: Does T Stamp Inc stock reflect fundamentalsJuly 2025 Sentiment & Smart Allocation Stock Tips - baoquankhu1.vn
Will BioNexus Gene Lab Corp. stock recover after earningsInsider Selling & Smart Swing Trading Alerts - mfd.ru
BGLC Should I Buy - Intellectia AI
Analyst Upgrade: What is the Moat Score of BioNexus Gene Lab CorpJuly 2025 Rallies & Weekly Market Pulse Alerts - baoquankhu1.vn
BioNexus Launches Regional Deployment of VitaGuard MRD Infrastructure; Positioned to Challenge Legacy Oncology Platforms Across ASEAN's Multi-Billion Dollar Market - Finviz
BioNexus Launches Regional Deployment of VitaGuard™ MRD Infrastructure; Positioned to Challenge Legacy Oncology Platforms Across ASEAN’s Multi-Billion Dollar Market - marketscreener.com
BioNexus Launches Regional Deployment of VitaGuard™ MRD - GlobeNewswire
Analyst Calls: Is BioNexus Gene Lab Corp a strong candidate for buy and hold2025 Price Targets & Fast Exit/Entry Strategy Plans - baoquankhu1.vn
Block Trades: Will BioNexus Gene Lab Corp outperform its industry peersJuly 2025 Outlook & Fast Entry Momentum Alerts - baoquankhu1.vn
BioNexus Gene Lab stockholders back governance and incentive plan - MSN
Whale Trades: Can BioNexus Gene Lab Corp be the next market leaderMarket Performance Summary & Entry Point Confirmation Signals - baoquankhu1.vn
BioNexus Gene Lab Corp. (NASDAQ:BGLC) Short Interest Update - Defense World
Bearish Setup: Will BioNexus Gene Lab Corp outperform its industry peersJuly 2025 Summary & Consistent Return Investment Signals - baoquankhu1.vn
New Highs: Will QCR Holdings Inc stock recover after earningsDay Trade & Smart Swing Trading Alerts - baoquankhu1.vn
Why BioNexus Gene Lab Corp. stock is trending among retail tradersJuly 2025 Rallies & Precise Buy Zone Identification - Улправда
Insider Trends: Can BioNexus Gene Lab Corp. stock deliver sustainable ROEJuly 2025 Levels & Community Driven Trade Alerts - Улправда
How BioNexus Gene Lab Corp. stock reacts to job market dataJuly 2025 Intraday Action & Verified Stock Trade Ideas - Улправда
Can BioNexus Gene Lab Corp. stock deliver sustainable ROEJuly 2025 Levels & Community Driven Trade Alerts - ulpravda.ru
Why BioNexus Gene Lab Corp. stock is recommended by analystsJuly 2025 Chart Watch & AI Powered Market Entry Ideas - Улправда
Downgrade Watch: Can BioNexus Gene Lab Corp stock resist market sell offsShort Setup & Technical Pattern Alert System - moha.gov.vn
BioNexus Gene Lab Stockholders Back Governance and Incentive Plan - The Globe and Mail
BioNexus Gene Lab shareholders approve board, equity plan, and auditor at annual meeting - Investing.com Australia
BioNexus Gene Lab shareholders approve board, equity plan, and auditor at annual meeting By Investing.com - Investing.com South Africa
How supply chain issues affect BioNexus Gene Lab Corp. stockMarket Insider Reports & Capitalize On Fast Trends - bollywoodhelpline.com
BioNexus Gene Lab (NASDAQ:BGLC) Shares Down 0.2% – Should You Sell? - Defense World
BioNexus Gene Lab Shares Surge on Strategic MRD Testing Partnership - MSN
BioNexus Chemrex leadership resignations prompt governance review - The Globe and Mail
Bionexus Gene Lab CorpMatthew L. Barsing appointed as chairman of Chemrex boardSEC filing - marketscreener.com
Bionexus Gene Lab Corp (BGLC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.26%
자본화:
|
볼륨(24시간):